Jessica Soliz
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 98 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 28 manufacturers, the largest accounting for just 19.1% — the pattern of someone who eats at a lot of different presentations.
Across 98 payments — averaging $21.84 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$408
- Vanda Pharmaceuticals Inc.$237
- AstraZeneca$216
- Axsome Therapeutics, Inc.$142
- Otsuka America Pharmaceutical, Inc.$130
- Novo Nordisk$117
- plus $889 from 22 others
What the payments were for
- Food & beverage$2,140100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie | 16 | $408 |
| Vanda Pharmaceuticals Inc. | 8 | $237 |
| AstraZeneca | 10 | $216 |
| Axsome Therapeutics, Inc. | 6 | $142 |
| Otsuka America Pharmaceutical, Inc. | 6 | $130 |
| Novo Nordisk | 6 | $117 |
| Lilly USA, LLC | 5 | $102 |
| Novartis | 3 | $98 |
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) | 4 | $79 |
| Takeda Pharmaceuticals U.S.A., Inc. | 4 | $72 |
| Lundbeck LLC | 4 | $58 |
| Neurocrine Biosciences, Inc. | 3 | $50 |
| Aimmune Therapeutics, Inc. | 2 | $45 |
| Boehringer Ingelheim | 2 | $44 |
| Collegium Pharmaceutical, Inc. | 2 | $41 |
| Teva Pharmaceuticals USA, Inc. | 2 | $37 |
| Bayer | 2 | $37 |
| Alkermes, Inc. | 2 | $31 |
| Kowa Pharmaceuticals America, Inc. | 2 | $29 |
| GSK | 1 | $26 |
| Harmony Biosciences LLC | 1 | $24 |
| Almatica Pharma LLC | 1 | $18 |
| Supernus Pharmaceuticals, Inc. | 1 | $18 |
| Actelion Pharmaceuticals US, Inc. | 1 | $17 |
| Eisai Inc. | 1 | $17 |
| Amgen | 1 | $16 |
| Exact Sciences | 1 | $15 |
| Pfizer | 1 | $15 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- VRAYLAR$125
How this compares
$2,140 in reported general payments places this provider in the 85th percentile of 4,941 family providers in Illinois.
Other family in Milan
- Ruth CarricoChicago$578K
- Aleksandra BielawiecBarrington$373K
- Erin SieberNaperville$334K
- Jamie BroganChicago$282K
- Ashley NoethGlen Carbon$271K
- Marita KametasChicago$259K
- Shammona ClarkChicago$247K
- Amanda McKeeMount Vernon$242K
- Amy BrownellElk Grove Village$202K
- Brittony CroasdellChicago$192K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.